Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Seung Mi Lee, Won Kim
Clin Mol Hepatol. 2022;28(1):47-49.   Published online 2021 Nov 30     DOI: https://doi.org/10.3350/cmh.2021.0338
Citations to this article as recorded by Crossref logo
Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study
Seung Mi Lee, Geum Joon Cho, Won Young Wi, Errol R. Norwitz, Bo Kyung Koo, Jeesun Lee, Young Mi Jung, Soo Heon Kwak, Chan-Wook Park, Jong Kwan Jun, Sae Kyung Joo, Min-Jeong Oh, Won Kim, Joong Shin Park
Hepatology International.2023; 17(2): 367.     CrossRef
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies
George Agyapong, Farzaneh Dashti, Bubu A. Banini
Annals of the New York Academy of Sciences.2023; 1526(1): 16.     CrossRef
Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome
Luca Marozio, Francesca Dassie, Gianluca Bertschy, Emilie M. Canuto, Gabriella Milan, Stefano Cosma, Pietro Maffei, Chiara Benedetto
Frontiers in Genetics.2022;[Epub]     CrossRef